A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants
Clinical trial NCT04548219 · COMPLETED
Trial details
- NCT number
- NCT04548219
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2021-01-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.